Advanced Biomedical Technologies Inc (ABMT) Return on Equity ROE from the third quarter 2021 to third quarter 2020 and annually, average high and low, overall ranking from Jul 31 2021 to Jul 31 2020 - CSIMarket
CSIMarket
 


Advanced Biomedical Technologies Inc   (ABMT)

Advanced Biomedical Technologies Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Advanced Biomedical Technologies Inc in the third quarter 2021?
Due to the lack of equity, it was not possible to calculate Advanced Biomedical Technologies Inc 's return on equity (ROE) in its third quarter 2021

What is ROE?




Return On Equity (Jul 31 2021)
III. Quarter
(Apr 30 2021)
II. Quarter
(Jan 31 2021)
I. Quarter
(Oct 31 2020)
IV. Quarter
(Jul 31 2020)
III. Quarter
Y / Y Equity Change - - - - -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -1 -1 -1 -1 -1
Return On Equity (TTM) - - - - -
ABMT's Total Ranking # # # # #
Equity (TTM) in Millions -8 -8 -8 -7 -7
Seq. Equity Change - - - - -
Seq. Net Income Change - - - - -

Return On Equity Company Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Equity Statistics
High Average Low
0 %
0 %
0 %
 





ABMT Annual Return On Equity (Oct 31 2020)
2020
(Oct 31 2019)
2019
(Oct 31 2018)
2018
(Oct 31 2017)
2017
(Oct 31 2016)
2016
Total Equity in Millions -7 -6 -6 -5 -4
Y / Y Equity Change - - - - -
Net Income in Millions -1 -1 -1 -1 -1
Y / Y Net Income Change - - - - -
Return On Equity - - - - -





More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
ABMT's' Return on Equity at Yahoo Finance
ABMT's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for ABMT's Competitors
Subscribers only: Roe for Advanced Biomedical Technologies Inc 's Suppliers
Subscribers only: Return On Equity for ABMT's Customers




Companies with similar Return On Equity at Jul 31 2021, within Healthcare Sector ROE
Phibro Animal Health Corporation  26.05 %
Bruker Corporation  24.72 %
Blueprint Medicines Corporation  24.65 %
Meridian Bioscience Inc   24.61 %
Crispr Therapeutics Ag  24.08 %
Encompass Health Corporation  24.07 %
Bionexus Gene Lab Corp   23.39 %
U S Physical Therapy Inc  23.06 %
Biogen Inc   23.01 %
Vertex Pharmaceuticals Inc  22.76 %
Conformis inc   22.58 %
Ensign Group Inc  22.42 %
Align Technology inc   21.42 %
Medpace Holdings Inc   21.23 %
Agilent Technologies inc   20.31 %
National Healthcare Corp  20.24 %
Emergent Biosolutions Inc   20.24 %
Biomarin Pharmaceutical Inc  20.22 %
Harmony Biosciences Holdings inc   20.18 %
Lakeland Industries Inc   20.13 %
Avid Bioservices Inc   19.89 %
Royalty Pharma Plc  19.60 %
Merck and Co Inc   19.41 %
Abbott Laboratories  19.26 %
Corcept Therapeutics Inc  19.08 %
Seagen Inc   19.02 %
Charles River Laboratories International inc   18.79 %
Healthcare Services Group Inc   18.70 %
Allied Healthcare Products inc   17.87 %
Resmed Inc   17.62 %


Date modified: 2026-09-08T15:10:22+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.